- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Bernstein Neutral On Medtronic With Slowing ICD Market (MDT, STJ, BSX)
Recent Articles by Ted Friedman
- Gold Finishes Lower After Pressure from the Dollar (ABX, GOLD, GLD, GDX)
- Boeing Company’s Future Shows Positive Outlook (BA, LMT, GD, ERJ)
- Genzyme Reach Agreement with Relational Investors LLC (GENZ, HD)
- Barnes and Noble Reduces Outlook (BKS)
- Marks and Spencer Show Positive Sales Growth but Remains Cautious of 2010
Analyst Color
- General Growth Properties (GGP) Is Back In Favor
- JPMorgan Raises Its Estimates For Intel (INTC, JPM)
- Metabolix, Inc. (MBLX) Maintains Market Weight Rating
- Brean Murray Carret & Co. Believes Pullback In Bruker Represents Opportunity (BRKR)
- EnerNOC, Inc. (ENOC) Maintains Overweight Rating
Guidance
- Operating Profits At FedEx (FDX) May Rise 9% Annually
- Palm’s Survival Doubtful Going Forward
- ICx Technologies, Inc. (ICXT) Reports Fourth-Quarter Results
- FedEx Corporation’s (FDX) Third-Quarter Profit Beats Expectations
- Discover Financial Services (DFS) Maintains Outperform Rating
Analyst Ratings
Posted on 11/16/09 at 10:11am by Ted Friedman
Bernstein Research released their analysis of Medtronic Inc. (NYSE: MDT) and has a neutral stance for the stock with a price target of $40.
Bookmark/Search this post with:
Related Articles
Today's Trading Ideas
Featured Articles
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.
